Cargando…

Silencing TRIP13 inhibits cell growth and metastasis of hepatocellular carcinoma by activating of TGF-β1/smad3

BACKGROUND: TRIP13 is highly expressed in several cancers and is closely connected with cancer progression. However, its roles on the growth and metastasis of hepatocellular carcinoma (HCC), and the underlying mechanism are still unclear. METHODS: Combining bioinformatics with previous studies, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Jianning, Zhang, Xuexiu, Li, Jiaheng, Zhao, Dongyao, Gao, Bing, Zhou, Haining, Gao, Shilin, Zhang, Lianfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296061/ https://www.ncbi.nlm.nih.gov/pubmed/30564064 http://dx.doi.org/10.1186/s12935-018-0704-y

Ejemplares similares

Hsa_circ_0026628 promotes the development of colorectal cancer by targeting SP1 to activate the Wnt/β-catenin pathway
por: Zhang, Xuexiu, et al.
Publicado: (2021)

HOXC6 gene silencing inhibits epithelial-mesenchymal transition and cell viability through the TGF-β/smad signaling pathway in cervical carcinoma cells
por: Zhang, Feng, et al.
Publicado: (2018)

Circular RNA circ-CSPP1 regulates CCNE2 to facilitate hepatocellular carcinoma cell growth via sponging miR-577
por: Sun, Qian, et al.
Publicado: (2020)

FAM225A facilitates colorectal cancer progression by sponging miR‐613 to regulate NOTCH3
por: Zhang, Xuexiu, et al.
Publicado: (2020)

RNAi silencing of c-Myc inhibits cell migration, invasion, and proliferation in HepG(2) human hepatocellular carcinoma cell line: c-Myc silencing in hepatocellular carcinoma cell
por: Zhao, Yan, et al.
Publicado: (2013)

Echinacoside exerts anti-tumor activity via the miR-503-3p/TGF-β1/Smad aixs in liver cancer
por: Li, Wen, et al.
Publicado: (2021)

UBE2I promotes metastasis and correlates with poor prognosis in hepatocellular carcinoma
por: Yang, Hao, et al.
Publicado: (2020)

TRIP6 enhances stemness property of breast cancer cells through activation of Wnt/β-catenin
por: Zhao, Xiaohui, et al.
Publicado: (2020)

MicroRNA-10b regulates epithelial–mesenchymal transition by modulating KLF4/KLF11/Smads in hepatocellular carcinoma
por: Hujie, Gulibaha, et al.
Publicado: (2018)

MiR-519d facilitates the progression and metastasis of cervical cancer through direct targeting Smad7
por: Zhou, Jue-Yu, et al.
Publicado: (2016)

Mechanistic insight into TRIP13-catalyzed Mad2 structural transition and spindle checkpoint silencing
por: Brulotte, Melissa L., et al.
Publicado: (2017)

Long non-coding RNA NORAD exhaustion represses prostate cancer progression through inhibiting TRIP13 expression via competitively binding to miR-495-3p
por: Chen, Fengling, et al.
Publicado: (2020)

DNA methylation affects metastasis of renal cancer and is associated with TGF-β/RUNX3 inhibition
por: Zheng, Jianbo, et al.
Publicado: (2018)

Silencing of PSMC2 inhibits development and metastasis of prostate cancer through regulating proliferation, apoptosis and migration
por: Chen, Qingke, et al.
Publicado: (2021)

Circular RNA hsa_circ_0000517 modulates hepatocellular carcinoma advancement via the miR-326/SMAD6 axis
por: He, Shuwei, et al.
Publicado: (2020)

CDP138 silencing inhibits TGF-β/Smad signaling to impair radioresistance and metastasis via GDF15 in lung cancer
por: Lu, Yanwei, et al.
Publicado: (2017)

Overexpression of mircoRNA-137 inhibits cervical cancer cell invasion, migration and epithelial–mesenchymal transition by suppressing the TGF-β/smad pathway via binding to GREM1
por: Miao, Hui, et al.
Publicado: (2019)

LINC00221 silencing prevents the progression of hepatocellular carcinoma through let-7a-5p-targeted inhibition of MMP11
por: Yang, Lin, et al.
Publicado: (2021)

SHC4 promotes tumor proliferation and metastasis by activating STAT3 signaling in hepatocellular carcinoma
por: Zhang, Xin, et al.
Publicado: (2022)

TGF beta1 and related-Smads contribute to pulmonary metastasis of hepatocellular carcinoma in mice model
por: Li, Guo-Cai, et al.
Publicado: (2012)

Silencing Formin-like 2 inhibits growth and metastasis of gastric cancer cells through suppressing internalization of integrins
por: Zhong, Banghua, et al.
Publicado: (2018)

TGF-β isoforms induce EMT independent migration of ovarian cancer cells
por: Gao, Jingfang, et al.
Publicado: (2014)

Loss of PR55α promotes proliferation and metastasis by activating MAPK/AKT signaling in hepatocellular carcinoma
por: Zhao, JiangSheng, et al.
Publicado: (2021)

Organ microenvironment affects growth and metastasis of hepatocellular carcinoma via the TGF-β/Smad pathway in mice
por: LI, GUOCAI, et al.
Publicado: (2013)

Sufferings in silence: Violence against female workers in the ready-made garment industry in Bangladesh: A qualitative exploration
por: Akhter, Sadika, et al.
Publicado: (2019)

Piezo1 promoted hepatocellular carcinoma progression and EMT through activating TGF-β signaling by recruiting Rab5c
por: Li, Yi-ming, et al.
Publicado: (2022)

Genomic profiling of colorectal cancer with isolated lung metastasis
por: Zhang, Nan, et al.
Publicado: (2020)

Looking for Ted: black trips, “psychedelic” humanism, and silence
por: Cordova, Michael
Publicado: (2023)

LncRNA NEAT1 promotes proliferation, migration, invasion and epithelial-mesenchymal transition process in TGF-β2-stimulated lens epithelial cells through regulating the miR-486-5p/SMAD4 axis
por: Wang, Huajun, et al.
Publicado: (2020)

Silenced lncRNA DDX11-AS1 or up-regulated microRNA-34a-3p inhibits malignant phenotypes of hepatocellular carcinoma cells via suppression of TRAF5
por: Ding, Gangqiang, et al.
Publicado: (2021)

Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma
por: Liu, Gao-Min, et al.
Publicado: (2019)

ZKSCAN3 drives tumor metastasis via integrin β4/FAK/AKT mediated epithelial–mesenchymal transition in hepatocellular carcinoma
por: Li, Jieqiong, et al.
Publicado: (2020)

MicroRNA-23a regulates epithelial-to-mesenchymal transition in endometrial endometrioid adenocarcinoma by targeting SMAD3
por: Liu, Ping, et al.
Publicado: (2016)

Targeting TRIP13 for overcoming anticancer drug resistance (Review)
por: Zhao, Liwen, et al.
Publicado: (2023)

SCUBE3 downregulation modulates hepatocellular carcinoma by inhibiting CCNE1 via TGFβ/PI3K/AKT/GSK3β pathway
por: Xu, Pan, et al.
Publicado: (2022)

Disassembly of the Shieldin Complex by TRIP13
por: Sarangi, Prabha, et al.
Publicado: (2020)

ZHX2 inhibits thyroid cancer metastasis through transcriptional inhibition of S100A14
por: Zhang, Yankun, et al.
Publicado: (2022)

TRIP13 overexpression in hepatocellular carcinoma: implications for poor prognosis and immune cell infiltration
por: Xue, Jiapeng, et al.
Publicado: (2023)

A novel 4-gene signature for overall survival prediction in lung adenocarcinoma patients with lymph node metastasis
por: Wang, Yanfang, et al.
Publicado: (2019)

Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4
por: Zhu, Meng-Xuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kqlof1p2i9gm0d1jkam30jgvpu